We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Type 2 myocardial infarction occurs due to a mismatch ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Causes of MI such as hypoxemia and anemia, also tied to ...

The hospital and post-discharge course of patients diagnosed with type-2 myocardial infarction (MI), triggered when myocardial oxygen demand outstrips supply, differs in telling ways from those with ...

HealthDay News — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...

Type 2 myocardial infarction (T2MI) occurs less frequently than type 1 myocardial infarction (T1MI) among patients presenting to the emergency department with chest pain, but clinical outcomes for the ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Perhaps 40% of hospitalized patients with type 2 myocardial infarction (MI) are not evaluated by a cardiologist at the same admission, suggests a study based on experience over several years at a ...

A non-ST segment elevation myocardial infarction, also called an NSTEMI or a non-STEMI, is a type of heart attack. While it's often less damaging to your heart than a STEMI, it's still a serious ...